Filipa Sousa / Science writing

Portfolio · Science communication

Science explained for non-specialists.

In 2021, I wrote as a volunteer journalist for the Science and Health section of the Jornal Universitário do Porto (JUP), the University of Porto newspaper. In each article, I took a public-health topic and explained it using scientific studies, with editorial review by the paper. Below is a summary of each one, with a link to the full text.

Filipa Sousa · Jornal Universitário do Porto · 2021

01Jornal Universitário do Porto

Síndrome Pós-COVID‑19: Quando os sintomas permanecem após um teste negativo

What happens when COVID-19 symptoms persist after a negative test? In this article, I explain post-COVID syndrome, drawing on studies from Spain and the United Kingdom, and group the symptoms by body system, from fatigue to memory problems. At its centre is the account of a 26-year-old Portuguese woman who describes months of breathlessness, anxiety and difficulty finding words. I close with practical guidance on where to seek help and what support is available in Portugal.

Long COVIDInterviewPublic health
Read the full article on JUP (in Portuguese)

02Jornal Universitário do Porto

Ensaios Clínicos de Vacinas COVID‑19: Olimpíadas Científicas 20/21

If a vaccine normally takes 5 to 10 years to reach the market, how did COVID-19 vaccines arrive so quickly? In this article, I walk through the stages of vaccine development, from preclinical research to post-marketing pharmacovigilance, and what shortened the timelines without skipping safety steps: decades of prior research, trials with thousands of volunteers, overlapping phases and regulatory review in parallel. I end with the challenges that remained: variants, long-term safety, global distribution and public trust.

Clinical trialsVaccinesRegulation
Read the full article on JUP (in Portuguese)

03Jornal Universitário do Porto

Imunidade de Grupo – o que é e qual a sua importância?

An epidemiology concept explained for everyone. In this article, I define herd immunity and the threshold above which a disease stops circulating, with examples such as measles (about 95%) and polio (about 80%). I show why that calculation is hard for COVID-19, with waning immunity, new variants and pockets of unvaccinated people, and put Portugal’s target in context, revised from 70% to 85% after the Delta variant arrived.

EpidemiologyVaccinationPublic health
Read the full article on JUP (in Portuguese)

04Jornal Universitário do Porto

A Conquista Histórica na Luta contra a Malária

The first vaccine against a parasite approved by the WHO. In this article, I trace more than 30 years of development of RTS,S, explain how it acts when the parasite reaches the liver and summarise the trials and pilot programmes in Ghana, Kenya and Malawi, which showed a 30% drop in hospital admissions for severe malaria. I discuss what is still needed to reach more children (funding, supply and equitable access) and present the vaccine as a complement to bed nets and other measures, not a replacement.

MalariaVaccinesGlobal health
Read the full article on JUP (in Portuguese)

I also wrote a fifth article, on Tarui disease (a rare metabolic disorder), which is not available online. Summaries written by me. The original articles belong to the Jornal Universitário do Porto.

I also publish in scientific journals

I have 6 peer-reviewed publications, 5 as first author, with 324 citations. The full list is in the portfolio.

See publications

Looking for a scientific or medical writer?

I’m a pharmacist with a PhD in Pharmaceutical Sciences and experience in scientific writing, editing and drug information. I work remotely or hybrid, from Porto, Portugal.